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Abstract The pharmacology of Caenorhabditis elegans
glutamate-gated chloride (GluCl) channels was determined
by making intracellular voltage-clamp recordings from
Xenopus oocytes expressing GluCl subunits. As previously
reported (Cully et al. 1994), GluCla1b responded to gluta-
mate (in a picrotoxin sensitive manner) and ivermectin,
while GluClb responded only to glutamate and GluCla1 only
to ivermectin. This assay was used to further investigate the
action of chloride channel compounds. The aryl-
aminobenzoate, NPPB, reduced the action of glutamate on
the heteromeric GluCla1b channel (IC50 6.03 ± 0.81 lM).
The disulphonate stilbene, DNDS, blocked the effect of both
glutamate and ivermectin on GluCla1b channels, the action
of glutamate on GluClb subunits, and the effect of ivermectin
on GluCla1 subunits (IC50s 1.58–3.83 lM). Surprisingly,
amobarbital and pentobarbital, otherwise known as positive
allosteric modulators of ligand-gated chloride channels,
acted as antagonists. Both compounds reduced the action of
glutamate on the GluCla1b heteromer (IC50s of 2.04 ± 0.5
and 17.56 ± 2.16 lM, respectively). Pentobarbital reduced
the action of glutamate on the GluClb homomeric subunit
with an IC50 of 0.59 ± 0.09 lM, while reducing the
responses to ivermectin on both GluCla1b and GluCla1 with
IC50s of 8.7 ± 0.5 and 12.9 ± 2.5 lM, respectively. For
all the antagonists, the mechanism is apparently non-
competitive. The benzodiazepine, flurazepam had no
apparent effect on these glutamate- and ivermectin-gated
chloride channel subunits. Thus, arylaminobenzoates, dis-
ulphonate stilbenes, and barbiturates are non-competitive
antagonists of C. elegans GluCl channels.
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Introduction
Chloride channels probably occur in all cell types and may
be divided into those of neuronal origin, those present in
smooth and striated muscle, and those found in various
epithelia (Greger 1990). In neurones, there are chloride
channels involved in the maintenance of the resting
membrane potential and those that are ligand-gated, where
the ligand can be one of almost any of the classical
transmitters. However, GABA- and glycine-gated chloride
channels are particularly widespread in vertebrates (Olsen
and Tobin 1990; Betz 1991). In addition, there are a
number of invertebrate phyla, viz, arthropods, molluscs,
and nematodes, where there are also glutamate-gated
chloride channels (Cleland and Selverston 1998; Cull-
Candy 1976; Lea and Usherwood 1973a, b; Cully et al.
1994; Duan and Cooke 2000; Ikemoto and Akaike 1988;
Ikemoto et al. 1988; Kehoe and Vulfius 2000). Certain of
these channels have been cloned and are related structur-
ally to GABA- and glycine-gated chloride channels (Cully
et al. 1996). It has been proposed that these glutamate-
gated chloride channels are the counterparts of the verte-
brate glycine-gated channels (Vassilatis et al. 1997).
Ligand-gated chloride channels have been described where
glutamate and GABA share a receptor, e.g., on crayfish
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striated muscle (Franke et al. 1986), or where separate
glutamate and GABA receptors activate a common chlo-
ride channel, e.g., on Aplysia neurons (King and Carpenter
1987, 1989).
Glutamate- and ivermectin-gated chloride channel sub-
units have been identified in Caenorhabditis elegans, for
example, GluCla1 (Cully et al. 1994), GluCla2 (Dent et al.
1997), GluClb (Cully et al. 1994). Currently, a total of nine
glutamate-gated chloride–related cDNAs have been
isolated from C. elegans (http://www.wormbase.org 2004).
The M2 region of these subunits share high homology with
the bovine GABA-Aa1 subunit (Xu et al. 1995), the bovine
GABA-Ab1 subunit (Fisher et al. 1997), and the Drosophila
Rdl (resistance to dieldrin) GABA-A receptor (ffrench-
Constant et al. 1991). Studies by Cully et al. (1994) have
shown that the C. elegans GluCla1 subunit contained the
ivermectin-binding site while the GluClb subunit bound
glutamate. The GluCla1b heteromer was insensitive to
GABA and glycine together with the mammalian glutamate
agonists N-methyl-D-aspartate (NMDA), a-amino-3-
hydroxy-5-methyl-isoxazol propionic acid (AMPA), and
kainate (Cully et al. 1994). The GluCla1b heteromer was
also insensitive to the NMDA receptor antagonist, 6-cyano-
7-nitroquinoxaline-2,3-dione (CNQX) but was sensitive to
the non-competitive GABA-A antagonist, picrotoxin.
However, the sensitivity to picrotoxin varied, e.g., homo-
meric GluCla1 and the heteromeric GluCla1b receptors had
similar sensitivities with an IC50 of around 50 lM, while
homomeric GluClb receptors were about 1,000 times more
sensitive (Cully et al. 1996). This suggests that the subunit
composition has an important role in the pharmacology of
glutamate-gated chloride (GluCl) channels.
Chloride channel blockers comprise a very heteroge-
neous group of compounds, and antagonists of neuronal
chloride channels have nothing in common with blockers
of the epithelial chloride channels (Greger 1990). The
arylaminobenzoate, 5-nitro-2-(3-phenylpropylamino)ben-
zoic acid (NPPB), and the disulphonate stilbene derivative,
4,4-dinitrostilbene-2,2-disulphonic acid (DNDS) are
examples of non-specific chloride channel blockers which
act on ion channels in neurones, muscle, and kidney epi-
thelia (Greger 1990; Wangemann et al. 1986). The pres-
ence of a propyl group separating the phenyl ring and the
amino group in NPPB is optimal while an anionic site is
mandatory for chloride-blocking activity (Greger 1990).
The blocking ability of NPPB and DNDS varies between
preparations. For example, both NPPB and DNDS decrease
a glutamate-gated chloride channel on salamander cone
photoreceptors (Picaud et al. 1995). There is a chloride-
sensitive channel from rough endoplasmic reticulum
membranes of rat hepatocytes which is blocked by 300-lM
NPPB while DNDS failed to inhibit this channel (Eliassi
et al. 1997). Other chloride channels are resistant to both
NPPB and DNDS, e.g., the cAMP-activated apical mem-
brane chloride channels in Necturus gallbladder epithelium
(Copello et al. 1993). Another arylaminobenzoate, flufen-
amic acid, 200 lM, reduced the response to 1 lM iver-
mectin on GluCla1b subunits expressed in oocytes by 60%
(Cully et al. 1994) but had no effect when applied at
100 lM on the response to 50 lM glutamate on native
glutamate-gated chloride channels in C. elegans pharynx
(Pemberton et al. 2001).
Both barbiturates and benzodiazepines bind to specific
modulatory sites on mammalian GABA-A-gated chloride
channel receptors (Olsen 1982). Barbiturates enhance the
action of GABA at these receptors (Birnir et al. 1997)
while benzodiazepines also enhance the action of GABA-A
receptors but can act through a range of sedative, hypnotic,
anxiolytic, and muscle-relaxant actions (Costa et al. 1975).
The benzodiazepine-binding site is located on the GABA-
A a subunit but the presence of a c subunit is also required
(Sigel and Buhr 1997). In contrast, the barbiturate-binding
site is located on the GABA-A b subunit and does not
require the presence of a c subunit for activation. Both
receptor sites are distinct from the GABA-binding site
(Leeb-Lundberg et al. 1980). The barbiturate-binding site
is associated with that for picrotoxin (Smith and Olsen
1995; Thompson et al. 1996). Picrotoxin inhibits GABA
responses in a non-competitive manner (Simmonds 1982)
by acting deep within the chloride channel of the GABA-A
receptor in the Val257-Thr261 region near the putative
cytoplasmic end of M2 of the a1 subunit (Xu et al. 1995).
The present study sets out to determine the actions of
NPPB, DNDS, amobarbital, pentobarbital, and flurazepam
on C. elegans glutamate-gated GluCla1b and GluClb
subunits and C. elegans ivermectin-gated GluCla1b and
GluCla1 subunits expressed in Xenopus oocytes in an
attempt to further define the pharmacological profile of
C. elegans glutamate- and ivermectin-gated chloride channels.
Materials and methods
In vitro transcription of cDNA
cDNA clones of the C. elegans glutamate-gated chloride
channel a1 and b subunits were obtained from Merck
(Rahway, New Jersey, USA). They were inserted into
pBluescript
TM
S4 plasmids (Stratagene), in between the
Not1 and EcoRV restriction enzyme cleavage sites. The
plasmids were transformed into E. coli (XL1-BLUE,
Stratagene) bacteria and incubated in LB medium. The
plasmids were isolated from the cells using a QIAgen
plasmid purification kit (QIAgen, Crawley, W. Sussex,
UK). The clones were then excised from the plasmids using
the restriction enzymes Not 1 and Sac 1 (Promega,
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Southampton, UK) and purified with phenol to remove any
contaminating proteins.
The transcription was performed using a RiboMAX
TM
large-scale RNA production system (Promega, UK). Lin-
earized DNA was incubated with an RNA polymerase, a
ribonuclease inhibitor, and a mixture of the four nucleo-
tides. This mixture was incubated for 3 h at 30C. At the
end of that time, a DNase was added to remove the original
DNA from the sample. Small samples were then taken
from the mixture and treated with TCA for measurement of
radiolabel incorporation. The transcripts were cleaned
using an RNeasy
TM
spin column (QIAgen, Crawley, UK), a
small sample was run on an RNA gel to check integrity,
and the remainder was stored as an ethanolic precipitate
until required for injection into oocytes.
Small samples of the transcripts were translated in the
rabbit reticulocyte lysate cell-free translation system
(Promega, UK) in order to ascertain that the translation
products of the transcripts were of the correct size.
Oocyte preparation and injection
Mature female Xenopus laevis were purchased from
Blades Biologicals (Edenbridge, Kent, UK) and kept in
30 cm deep filtered tap water at about 15C. The water
was left to stand for several days before the toads were
placed in it to allow dispersal of any chlorine. To obtain
oocytes, a toad was anaesthetized in a cold 1.5% w/v
aqueous solution of ethyl-m-aminobenzoate (tricaine;
Sigma, Poole, UK) for about 40 min. A small incision
(about 1 cm) was made into the ventral surface of the
abdominal cavity above the bladder to one side of the
midline. Several lobes of the ovary were removed and
placed in calcium-free standard oocyte saline (SOS) and
the body wall and skin sutured separately. SOS had the
following composition: NaCl 100; KCl 2; CaCl2 1.8;
MgCl2 1.0; HEPES 5; all values in mM. The pH was
adjusted to 7.6 before use. For calcium-free SOS, the
CaCl2 was simply omitted.
The oocytes were treated with a 2 mg ml-1 solution of
collagenase for 15–20 min. The cells were then manually
separated from each other and stored in SOS at 4C until
required for injection.
Pipettes for injecting RNA were pulled from thin-
walled capillary tubes on a two-stage vertical electrode
puller. The tip of the micropipette was broken under a
microscope to a diameter of 10–15 lm and filled with
mineral oil to maintain a constant interface between the
RNA solution and the pressure port. The micropipette
was attached to a microelectrode holder with a pressure
port in a hydraulic microdrive. The concentration of the
RNA solution was 1 lg ml-1 in each case. In the case of
the GluCla1/GluClb mixture, the ratio of the two
subunits was 1:1. A drop of RNA solution was placed on
a piece of sterile paraffin film and drawn up into the
pipette. The oocytes to be injected were placed in a drop
of SOS medium to prevent movement of the cell. Each
cell was injected with 50 nl of the RNA solution and
then kept in sterile wells of SOS at 18–20C until
required.
Electrophysiological recordings from oocytes
A standard two-electrode voltage-clamp was used for
electrophysiological recording. The intracellular electrodes
were filled with 3 M potassium chloride (resistance,
1–2 MX). Silver/silver chloride wires connected the elec-
trodes to the headstage of an Axoclamp 2A current/volt-
age-clamp (Axon Instruments, California, USA). Signals
were monitored on a chart recorder. The oocyte was placed
in a perfusion chamber and perfused with SOS at a rate of
approximately 8 ml min-1. After impaling with two elec-
trodes, the oocyte was allowed to recover before voltage
clamping at -80 mV. Drugs were dissolved in SOS, or in
the case of ivermectin (22,23,dihydroavermectin B1A),
dissolved in DMSO and diluted in SOS to a final concen-
tration of DMSO \0.5%. The sodium salt of L-glutamate
was used to avoid possible pH effects. Drug application
was by local perfusion at a rate of about 8 ml min-1. A
bubble was introduced between the SOS and drug so that
the bubble escaped through a small hole immediately prior
to the bath to minimize agitation in the bath and allow
rapid on/off responses to be seen. Application of agonist
was 10 s in the case of glutamate and 30 s in the case of
ivermectin. Antagonists were applied for 3–5 min prior to
agonist application.
Data analysis
In each case, the experiments were repeated at least four
times. All values are quoted as mean ± standard error of
the mean. Error bars on graphs also show the standard error
of the mean. Concentration–response curves were fitted
using non-linear regression in GraphPad Prism (version 2,
San Diego, USA). Data on graphs are shown as a per-
centage of the maximum response. Unpaired Student’s t
tests were carried out where appropriate, and P \ 0.05 was
taken as significant.
Drugs
5-Nitro-2-(3-phenylpropylamino)benzoic acid (NPPB),
amobarbital, pentobarbital, flurazepam, ivermectin, gluta-
mate (sodium salt), and picrotoxin were obtained from
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Sigma–Aldrich. 4,4-Dinitrostilbene-2,2-disulphonic acid
(DNDS) was obtained from Fluorochem, UK.
Results
Effect of glutamate and ivermectin on glutamate- and
ivermectin-gated chloride channels
No responses to either glutamate or ivermectin were
obtained from un-injected or water injected control oocytes
(data not shown). DMSO (0.5%) (used as vehicle) neither
elicited a response nor reduced the amplitude of glutamate
responses in injected oocytes. The maximum response seen
to glutamate in oocytes injected with GluCla1 and GluClb
in a 1:1 ratio to form a GluCla1b heteromer was 4.2 lA,
and the EC50 for glutamate on this heteromer was
1.8 ± 0.3 mM (n = 13), Table 1. The EC50 for glutamate
on the homomer, GluClb, was 0.8 ± 0.08 mM (n = 9)
which was significantly different from the EC50 for the
heteromer, P \ 0.001. The maximum response seen to
ivermectin in oocytes injected with the heteromer was
3.4 lA with an EC50 of 1.02 ± 0.06 lM (n = 10),
Table 1. The EC50 for ivermectin on the homomer, Glu-
Cla1, was 0.97 ± 0.05 lM (n = 10). However, there was
no significant difference between the EC50 values on the
heteromer and GluCla1 homomer. The Hill coefficients of
the concentration–response curves for glutamate were
similar for the heteromer, 1.3 ± 0.2, and the b homomer,
1.8 ± 0.4, Table 1. However, the Hill coefficients for the
concentration–response curves for ivermectin were signif-
icantly different with values of 2.1 ± 0.2 and 1.4 ± 0.1,
for the heteromer and the GluCla1 homomer, respectively,
P \ 0.05. A Hill coefficient of greater than one implies that
more than one agonist molecule is required to gate the
channel. The glutamate responses of GluCla1b reversed
within a few seconds while those of ivermectin took much
longer to reverse, i.e., around 80% reversal over 45–
60 min. The reversal potential of the response of the
GluCla1b heteromer to glutamate was -21 mV, a value
equal to the reversal potential for chloride in the system.
The effect of picrotoxin and non-selective chloride
channel blockers on glutamate- and ivermectin-gated
chloride channels
Three compounds were tested on the GluCl channels, viz,
picrotoxin, NPPB, and DNDS. The IC50 values are summa-
rized in Table 2. Picrotoxin (100 lM) blocked the response
of GluCla1b to glutamate in a non-competitive manner
(Fig. 1a; n = 6). In a further series of experiments, the effect
of a range of concentrations of picrotoxin at blocking the
response to 1 mM glutamate was tested. Picrotoxin blocked
the response with an IC50 of 18.52 ± 1.02 lM (n = 5;
Fig. 1b; Table 2). The non-selective chloride channel
blocker NPPB (100 lM) also reduced the maximum
response of oocytes expressing GluCla1b to glutamate
(Fig. 1c; n = 4) i.e., acting in a non-competitive manner.
Experiments to determine the IC50 against 1 mM glutamate
showed that this compound was significantly more potent
than picrotoxin (IC50 of 6.03 ± 0.81 lM, n = 4; P \ 0.05;
Fig. 1d; Table 2). Another non-selective chloride channel
blocker, DNDS, 100 lM, also reduced the glutamate
response of the GluCla1b heteromer in a similar non-com-
petitive manner to NPPB (Fig. 1e; n = 5). Further experi-
ments testing this compound against the response to 1 mM
glutamate yielded an IC50 of 1.58 ± 0.34 lM, (Fig. 1f;
n = 5; Table 2). Therefore, this compound was significantly
more potent than either picrotoxin or NPPB, P \ 0.05. The
effect of DNDS on the glutamate response in oocytes
expressing the GluClb homomer was similar with an IC50 of
2.38 ± 0.26 lM (n = 4; Table 2). DNDS, 100 lM, also
reduced the response to ivermectin in oocytes expressing
GluCla1b in a non-competitive manner (Fig. 2a, c; n = 5).
Experiments to test the ability of DNDS to block the response
to 500 nM ivermectin yielded an IC50 of 3.52 ± 0.30
(n = 4; Table 2). DNDS also exhibited a similar non-com-
petitive block of the response to ivermectin for GluCla1
(100 lM DNDS, Fig. 2b, n = 5). The IC50 against 500 nM
ivermectin was 3.83 ± 0.30 lM (n = 4; Table 2).
Table 1 A summary of the effect of glutamate and ivermectin on
GluCl channels
Agonist Channel EC50 Hill coefficient n
Glutamate GluCla1b 1.8 ± 0.3 mM 1.3 ± 0.2 13
Glutamate GluClb 0.8 ± 0.08 mM 1.8 ± 0.4 9
Ivermectin GluCla1b 1.02 ± 0.06 lM 2.1 ± 0.2 10
Ivermectin GluCla1 0.97 ± 0.05 lM 1.4 ± 0.1 10
The values are given for the EC50s of glutamate and ivermectin
against either the heteromeric or homomeric channels as indicated
Table 2 A summary of the effects of antagonists (100 lM) on GluCl
channels
Antagonist Agonist Channel IC50 lM n
Picrotoxin Glutamate GluCla1b 18.52 ± 1.02 5
NPPB Glutamate GluCla1b 6.03 ± 0.81 4
DNDS Glutamate GluCla1b 1.58 ± 0.34 5
DNDS Glutamate GluClb 2.38 ± 0.26 4
DNDS Ivermectin GluCla1b 3.52 ± 0.30 4
DNDS Ivermectin GluCla1 3.83 ± 0.30 4
The values are given for the IC50s against glutamate (1 mM) and
ivermectin (500 nM) for either the heteromeric or homomeric chan-
nels as indicated
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Effects of barbiturates on glutamate- and ivermectin-
gated chloride channels
The actions of two barbiturates, viz, amobarbital and
pentobarbital, were examined for their effects on the glu-
tamate and ivermectin responses on oocytes expressing
heteromeric and homomeric glutamate- and ivermectin-
gated chloride channels. The IC50 values are summarized
in Table 3. Amobarbital, 100 lM, reduced the maximum
glutamate response of oocytes expressing GluCla1b
(n = 4; Fig. 3a). The IC50 for this compound against
1 mM glutamate was 2.04 ± 0.50 lM, (n = 5; Fig. 3c).
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Fig. 1 The effect of chloride channel compounds on the glutamate
response of oocytes expressing GluCl channels. a GluCla1b.
Concentration–response curves for glutamate in the absence (filled
circle, solid line) and presence (filled upright triangle, dashed line) of
100 lM picrotoxin (PTX) (n = 6). b GluCla1b. Effect of varying the
concentration of picrotoxin on the response to 1 mM glutamate. The
results are presented as the percentage of the maximum response
obtained to 1 mM glutamate before the addition of antagonist
(n = 5). The response after a wash ([15 min) is as indicated. The
inset shows example traces to 1 mM glutamate before PTX (left), in
the presence of 1 mM PTX (middle) and after a wash ([15 min,
right). c GluCla1b. Concentration–response curves for glutamate in
the absence (filled circle, solid line) and presence (filled upright
triangle, dashed line) of 100 lM NPPB (n = 4). d GluCla1b. Effect
of varying the concentration of NPPB on the response to 1 mM
glutamate. The results are presented as the percentage of the
maximum response obtained to 1 mM glutamate before the addition
of antagonist (n = 4). The inset shows example traces to 1 mM
glutamate before NPPB (left), in the presence of 100 lM NPPB
(middle) and after a wash ([15 min, right). e GluCla1b. Concentra-
tion–response curves for glutamate in the absence (filled circle, solid
line) and presence (filled upright triangle, dashed line) of 100 lM
DNDS (n = 5). f Effect of varying the concentration of DNDS on the
response to 1 mM glutamate for GluCla1b (n = 5; filled upright
triangle, dashed line) and GluClb (n = 4; filled circle, solid line). The
results are presented as the percentage of the maximum response
obtained to 1 mM glutamate before the addition of antagonist. The
inset shows example traces to 1 mM glutamate for GluCla1b before
DNDS (left), in the presence of 1 mM DNDS (middle) and after a
wash ([15 min, right)
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Pentobarbital, 100 lM, reduced the glutamate response of
the heteromer (n = 6, Fig. 3b). The IC50 for this compound
against 1 mM glutamate was 17.56 ± 2.16 lM (n = 6;
Fig. 3c). For the GluClb homomer, the IC50 was
0.59 ± 0.09 lM (n = 4; Table 3). The response of the
GluCla1b heteromer and the GluCla1 homer to ivermectin
was also inhibited in a non-competitive manner by pento-
barbital (100 lM; n = 5 and n = 4, respectively; Fig. 4a,
b, d). The IC50s for this compound against 500 nM iver-
mectin was 8.7 ± 0.50 lM (n = 6) and 12.9 ± 2.5 lM for
the GluCla1b heteromer and the GluCla1 homer, respec-
tively (n = 5; Fig. 4c; Table 3). The benzodiazepine,
flurazepam, was tested for a modulatory effect on a 1 mM
glutamate response of the heteromer but found to have no
effect when applied at concentrations from 10 nM to 1 mM
(n = 4; data not shown).
Discussion
The GluCl subunits studied here, GluCla1 and GluClb, are
encoded by glc-1 and glc-2, respectively. The subunits
have 45% amino acid identity and 63% amino acid simi-
larity with each other, and around 21% of the subunit
amino acids are conserved in at least 75% of GABA-A and
glycine subunits with which they were compared (Cully
et al. 1996). This conservation is strongest in the mem-
brane-spanning domains and the N-terminal domain.
However, these a1 and b subunits are insensitive to both
GABA and glycine and to bicuculline and strychnine
(Cully et al. 1994). Cully et al. found that the a1 subunit
homomer is activated by ivermectin while the b subunit
homomer responded to glutamate, an observation con-
firmed in the present study. The EC50 values obtained for
glutamate in the present study were similar to those
obtained by Cully et al., with the homomer being more
sensitive to glutamate. However, the EC50 values for
ivermectin were higher in the present study compared with
those obtained by Cully et al. The Hill coefficients obtained
for both glutamate and ivermectin on the heteromer and
both homomers were again similar between the study of
Cully et al. and the current study, suggesting that more than
one agonist molecule is required to gate the channels. In
contrast to the situation in C. elegans, the Drosophila
GluCla subunit is gated by both ivermectin and glutamate
(Cully et al. 1996). This subunit has 48% amino acid
identity and 60% nucleotide identity with the C. elegans
subunits. Its EC50 values for ivermectin and glutamate
were 41 nM and 23 lM, respectively, with Hill coefficients
greater than one.
Picrotoxin blocked the action of glutamate on the Glu-
Cla1b heteromer in the current study with an IC50 of
18.52 lM which is slightly lower than the value of 42 lM
obtained by Etter et al. (1999). While these authors found a
similar value for picrotoxin against ivermectin on the
heteromer, there was a large difference in the EC50 for
picrotoxin block of the homomers. In the case of GluCla1,
the value was 59 lM while for GluClb the value was
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a
b
c
+ DNDS
+ DNDS
%
 m
ax
 re
sp
on
se
%
 m
ax
 re
sp
on
se
100
-8 -7 -6 -5
-8 -7 -6 -5
0.1 0.5 1 50.1 0.5 1 5 
50nA
20s
100
Fig. 2 The effect of DNDS on the response to ivermectin.
a GluCla1b. Concentration–response curves for ivermectin in the
absence (filled circle, solid line) and presence (filled upright triangle,
dashed line) of 100 lM DNDS (n = 4). b GluCla1. Concentration–
response curves for ivermectin in the absence (filled circle, solid line)
and presence (filled upright triangle, dashed line) of 100 lM DNDS
(n = 5). c Example traces of cumulative responses to ivermectin
(0.1–5 lM, as indicated) for GluCla1b before DNDS (left) and in the
presence of 100 lM DNDS (right)
Table 3 A summary of the effects of barbiturates (100 lM) on
GluCl channels
Antagonist Agonist Channel IC50 lM n
Amobarbital Glutamate GluCla1b 2.04 ± 0.5 5
Pentobarbital Glutamate GluCla1b 17.56 ± 2.16 6
Pentobarbital Glutamate GluClb 0.59 ± 0.09 4
Pentobarbital Ivermectin GluCla1b 8.7 ± 0.50 6
Pentobarbital Ivermectin GluCla1 12.9 ± 2.5 5
The values are given for the IC50s against glutamate (1 mM) and
ivermectin (500 nM) for either the heteromeric or homomeric chan-
nels as indicated
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77 nM. Etter et al. concluded that picrotoxin blocked
GluCl channels by binding to a site accessible when the
channel was open. Picrotoxin weakly antagonised the
action of glutamate on the native receptor in the pharynx of
C. elegans, for example, 100 lM picrotoxin only reduced
the response to 50 lM glutamate by 25% (Pemberton et al.
2001). Using the heteromer expressed in Xenopus oocytes,
50 lM picrotoxin reduced the response to 300 lM gluta-
mate by 60% (Etter et al. 1999). Picrotoxin blocks other
invertebrate glutamate-gated chloride channels, including
the glutamate-gated chloride channels found on locust
striated muscle (Cull-Candy 1976; Lea and Usherwood
1973a, b) and glutamate-gated chloride channels of lobster
gastric mill muscle where high lM is required (Lingle and
Marder 1981). Interestingly, low lM picrotoxinin, the
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Fig. 3 The effect of barbiturates on glutamate responses in oocytes
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([15 min) is as indicated. The inset shows example traces to 1 mM
glutamate for GluCla1b before amobarbital (left), in the presence of
100 lM amobarbital (middle) and after a wash ([15 min, right)
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active component of picrotoxin, partially blocked gluta-
mate-gated chloride channels of Limulus polyphemus
neurones when glutamate was bath applied (Roberts and
Walker 1982). Picrotoxin is potent as an antagonist of
many invertebrate and vertebrate GABA-A receptors
(Nistri and Constanti 1979). Resistance to picrotoxin can be
achieved by mutating the 279 alanine of C. elegans GluClb
to threonine which is located in the second membrane-
spanning domain (Etter et al. 1999). A similar situation
occurs in insect GABA-A receptors, where a point muta-
tion at 279 alanine to serine provides resistance to dieldrin
and picrotoxin (ffrench-Constant et al. 1993). This dem-
onstrates the similarity between the glutamate- and GABA-
gated chloride channels for the picrotoxin site. Using a
chimera receptor composed of the N-terminal of GluCla1
and the C-terminal of GluClb, Etter et al. (1999) also
showed that the C-terminal contained a high affinity-
binding site for picrotoxin. In terms of their phylogenetic
relationship to other ligand-gated ion channels, it has been
proposed that the GluCl receptors of C. elegans may be
orthologous to the vertebrate glycine receptor (Vassilatis
et al. 1997) which itself may be derived from the GABA-A
receptor family (Ortells and Lunt 1995).
The two chloride channel blockers used in this study,
viz, NPPB and DNDS, are examples of arylaminobenzo-
ates and disulphonate stilbenes, respectively, and have
been tested for their blocking actions on a range of chloride
channels. There have been relatively few studies where
NPPB and DNDS have been tested against ligand-gated
chloride channel responses. For example, DNDS, DIDS,
and furosemide, 100 lM, reversibly reduced the response
of a peptide-gated chloride inhibitory response of Helix
aspersa neurons while NPPB had no blocking action
(Pedder et al. 1998). H. aspersa acetylcholine-gated chlo-
ride channels are also reversibly blocked by 180 lM SITS,
and this effect is non-competitive (Wright and Walker
1993). SITS, 100–500 lM, also reduced the GABA
response on dorsal root ganglion neurones in a reversible
and non-competitive manner without altering the GABA
reversal potential (Gallagher et al. 1983). In contrast, both
NPPB and DNDS have been widely studied in terms of
their mode of action as blockers of other types of chloride
channel. For example, disulphonate stilbenes such as DIDS
bind preferentially to the outward-facing state of the anion
transporter, AE1, of red blood cells (Jennings et al. 1998).
It is likely that they bind to exposed lysine residues pro-
ducing steric block of the ion transport mechanism (Abu-
ladze et al. 2005). In general, chloride currents in the heart
which are regulated by adenylyl cyclase-cAMP-PKA
(ICl.PKA) are relatively insensitive to disulphonate stilb-
enes but are blocked by arylaminobenzoates (Hume et al.
2000). Arylaminobenzoates block the cystic fibrosis
transmembrane conductance regulator (CFTR) when added
to either side of the membrane while disulphonate stilbenes
only block when added to the intracellular side of the
membrane (Sheppard and Welsh 1999). The disulphonate
stilbenes also inhibit single chloride channels prepared
from Torpedo californica electroplax and incorporated in
planar phospholipids bilayer membranes (Miller and White
1984).
In contrast to the situation with vertebrate GABA-A
receptors, barbiturates inhibited both glutamate- and iver-
mectin-gated responses of C. elegans GluCl channels with
IC50s in the low lM range. Amobarbital which was potent
against glutamate on the heteromer in this study was
inactive against the native glutamate-gated chloride chan-
nel in the pharynx of C. elegans (Pemberton et al. 2001),
perhaps reflecting a different subunit stoichiometry in this
tissue e.g., the presence of an avr-15 subunit rather than
glc-1. In contrast, pentobarbital, 100 lM, enhanced both
the amplitude and duration of the GABA responses of
cultured locust neurones by up to 70% (Lees et al. 1987).
At concentrations above 5 lM, pentobarbital also
enhanced ionophoretically applied GABA on locust-dis-
sociated neurones (von Keyserlingk and Willis 1992).
However, 300 lM thiopentone reversibly depressed the
amplitude of fast chloride-dependent glutamate inhibitory
events on snail neurones (Judge et al. 1979). This depres-
sion was followed by an increase in duration of the
response. These results demonstrate that invertebrate
ligand-gated chloride channels can be modulated by bar-
biturates although the direction of the modulation can vary.
It would be of interest to investigate the action of barbi-
turates on other invertebrate ligand-gated anion channels.
The Drosophila GABA-A subunit, RDL, is sensitive to
the benzodiazepine, 4-chlorodiazepam but not to fluni-
trazepam (Hosie and Sattelle 1996) while flunitrazepam,
but not diazepam, modulates the action of GABA on locust
neurones (von Keyserlingk and Willis 1992). Flunitraze-
pam-binding sites have been identified in the central ner-
vous system of insects but interestingly the most potent
ligand at displacing this binding, Ro5-4864, is selective for
the vertebrate peripheral benzodiazepine-binding site
(Lummis 1990). However, in the present study, the ben-
zodiazepine, flurazepam, failed to modulate C. elegans
GluCla1b subunits expressed in oocytes or the native
GluCl receptors in the pharynx (Pemberton et al. 2001). It
may be that the glutamate-gated chloride channels in
nematodes do not possess benzodiazepine modulatory
binding sites. Since there are nine glutamate-gated chloride
channels in C. elegans, it is possible that some of these may
be related to mammalian GABA-A c or d subunits and may
be necessary for benzodiazepine modulation. A third pos-
sibility, as demonstrated in insects, is that only certain
benzodiazepines may be active on nematode glutamate-
gated chloride channels (Nistri and Constanti 1978).
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In summary, the current study has provided further
information on the sensitivity of C. elegans GluCl channels
to chloride channel compounds. It confirmed the effect of
picrotoxin but failed to find evidence for a benzodiazepine-
binding site. However, it has demonstrated that both aryl-
aminobenzoates and disulphonate stilbenes act as non-
competitive antagonists at these channels. In terms of the
barbiturates, we can conclude that C. elegans GluCl
channels, in common with vertebrate GABA-A-gated
chloride channels, have a binding site. Intriguingly, evi-
dence from GABA receptors on Ascaris body wall muscle
suggests that these channels are insensitive to barbiturates
(Holden-Dye et al. 1989). Thus, a nematode glutamate-
gated chloride channel, but not a nematode GABA-gated
chloride channel, is sensitive to barbiturates. Furthermore,
in contrast to the vertebrate GABA-A receptor, barbiturates
act as negative, not positive, allosteric modulators of the
channels.
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